Edap Tms SA
NASDAQ:EDAP

Watchlist Manager
Edap Tms SA Logo
Edap Tms SA
NASDAQ:EDAP
Watchlist
Price: 4.09 USD
Market Cap: 152.9m USD
Section:
 

Relative Value

The Relative Value of one EDAP stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.09 USD, Edap Tms SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EDAP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.1
P/S
P/S
Price to Sales
2.1
vs History
71
vs Industry
60
Median 3Y
2.9
Median 5Y
3.7
Industry
2.4
Forward
2.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-4.1
Industry
22.9
Forward
-5.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
23
Median 3Y
-3.8
Median 5Y
49
Industry
14.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
15
Median 3Y
-3
Median 5Y
34.9
Industry
21.4
More Details
5.6
P/B
P/B
Price to Book Value
5.6
vs History
9
vs Industry
55
Median 3Y
3.8
Median 5Y
4.1
Industry
2.3
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
71
vs Industry
77
Median 3Y
2.3
Median 5Y
3.1
Industry
2.6
Forward
2.1
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
77
vs Industry
75
Median 3Y
6.9
Median 5Y
7.4
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-6.2
Industry
12.3
Forward
-6.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-9.2
Industry
17.2
Forward
-5.9
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
42
Median 3Y
-3.4
Median 5Y
40.1
Industry
15
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
35
Median 3Y
-2.7
Median 5Y
45
Industry
19
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
61
vs Industry
53
Median 3Y
2.8
Median 5Y
6.1
Industry
1.9
More Details

Multiples Across Competitors

EDAP Competitors Multiples
Edap Tms SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Edap Tms SA
NASDAQ:EDAP
152.9m USD 2.1 -6.7 -6.2 -6.2
US
Abbott Laboratories
NYSE:ABT
212.6B USD 4.8 15.2 19.4 27
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.2B USD 20 70.1 53.5 65.3
US
Stryker Corp
NYSE:SYK
138.2B USD 5.7 47.3 22.9 27.7
US
Boston Scientific Corp
NYSE:BSX
131.5B USD 6.8 47.3 27.7 37.6
IE
Medtronic PLC
NYSE:MDT
125.6B USD 3.6 26.3 14.8 21.5
DE
Siemens Healthineers AG
XETRA:SHL
51.9B EUR 2.2 24.2 13.6 19.2
US
Becton Dickinson and Co
NYSE:BDX
59.1B USD 2.7 35.5 12.9 21.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD 13.7 55.6 39.8 44.1
US
Edwards Lifesciences Corp
NYSE:EW
49B USD 8.3 35.7 25.6 28
US
Resmed Inc
NYSE:RMD
37.8B USD 7.2 26.3 18.9 20.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Edap Tms SA
NASDAQ:EDAP
Average EV/EBITDA: 24.9
Negative Multiple: -6.2 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.4
12%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
53.5
26%
2.1
US
Stryker Corp
NYSE:SYK
22.9
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
27.7
22%
1.3
IE
Medtronic PLC
NYSE:MDT
14.8
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.6
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.9
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.8
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.6
13%
2
US
Resmed Inc
NYSE:RMD
18.9
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Edap Tms SA
NASDAQ:EDAP
Average EV/EBIT: 31.3
Negative Multiple: -6.2 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
27
22%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
65.3
28%
2.3
US
Stryker Corp
NYSE:SYK
27.7
16%
1.7
US
Boston Scientific Corp
NYSE:BSX
37.6
32%
1.2
IE
Medtronic PLC
NYSE:MDT
21.5
17%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.2
15%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.9
21%
1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1
15%
2.9
US
Edwards Lifesciences Corp
NYSE:EW
28
13%
2.2
US
Resmed Inc
NYSE:RMD
20.9
12%
1.7

See Also

Summary
EDAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
EDAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EDAP stock valuation using valuation multiples.
Wall Street Estimates
EDAP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EDAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.